Integra LifeSciences Holdings (IART) Stock Analysis

Integra LifeSciences Holdings (IART) is a publicly traded company in the HEALTHCARE sector. It trades at $15.67, carries a market capitalization of $1.22B. This page summarizes the public market data, fundamentals, and frequently asked questions for IART, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $15.67
• Market Cap: $1.22B
• EPS: $-6.47
• 52-Week High: $16.70
• 52-Week Low: $8.70

Market Sentiment

Integra LifeSciences Holdings currently has a Neutral sentiment score of 0.14.

About Integra LifeSciences Holdings

Integra LifeSciences Holdings Corporation is a prominent global medical technology firm that specializes in the development and manufacture of innovative surgical implants and medical instruments for a range of applications, including neurosurgery, limb reconstruction, orthopedics, and general surgery. Based in Princeton, New Jersey, Integra is dedicated to improving patient outcomes through cutting-edge products that harness proprietary technologies and advanced research capabilities. With a...

GNG Research Analysis

GNG Research scores Integra LifeSciences Holdings (IART) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IART.

Frequently Asked Questions

Does IART pay dividends?

Integra LifeSciences Holdings (IART) does not currently pay a regular dividend.

What is IART's market cap?

Integra LifeSciences Holdings (IART) has a market capitalization of $1.22B with a current stock price of $15.67.